Association Between Statin Use and Risk of Dementia After a Concussion
Open Access
- 1 August 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 76 (8) , 887-896
Abstract
Concussions are a common cause of brain injury occurring in more than 1 million Americans each year and disproportionately involving older adults.1-4 The subacute consequences vary widely and include fatigue, headache, irritability, insomnia, inattention, photophobia, vertigo, and cognitive difficulties.5-9 Most patients recover from a concussion within weeks, although some can develop lingering mood disorders or chronic neuropsychiatric disorders.10-14 The extent of complications after a concussion is uncertain, and effective pharmacologic treatments remain elusive.15-17 Unfortunately, many medical treatments for traumatic brain injury that showed promise in animal models have subsequently failed in human clinical trials.18-22Keywords
This publication has 113 references indexed in Scilit:
- Interventions provided in the acute phase for mild traumatic brain injury: a systematic reviewSystematic Reviews, 2013
- The vascular depression hypothesis: mechanisms linking vascular disease with depressionMolecular Psychiatry, 2013
- Unintentional Discontinuation of Statins May Increase Mortality After Traumatic Brain Injury in Elderly Patients: A Preliminary ObservationJournal of Clinical Medicine Research, 2013
- Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort studyBrain, 2012
- Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disordersPharmacological Research, 2011
- Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for PhysiciansJournal of General Internal Medicine, 2011
- Rates of Major Depressive Disorder and Clinical Outcomes Following Traumatic Brain InjuryJAMA, 2010
- Statin Therapy Inhibits Remyelination in the Central Nervous SystemThe American Journal of Pathology, 2009
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995